Skip to content

The effect of pomegranate juice on allergic rhinitis

The effect of sweet pomegranate juice on the severity of symptoms in patients with allergic rhinitis: A double-blinded, randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221012056153N1
Enrollment
60
Registered
2023-03-16
Start date
2022-12-22
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Allergic rhinitis, unspecified

Interventions

Intervention 1: Intervention group: Patients will receive sweet pomegranate juice concentrate (ml/day 50) for 2 months, in addition to taking antihistamine and corticosteroid drugs. Pomegranate concen

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Allergic rhinitis patients Patients who have been treated with standard drugs including antihistamines and corticosteroids for at least 4 weeks and have had a poor or no response to these treatments are included in the study.

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding Patients with non-allergic rhinitis Patients with systemic diseases Use of herbal supplements with antioxidant properties Liver dysfunction (LFT>3ULN) Kidney dysfunction (GFR<60 ml/kg/min) Thyroid disorders (based on thyroid function test) Epilepsy

Design outcomes

Primary

MeasureTime frame
Determining the severity of clinical symptoms of patients (including sneezing, an itchy nose, a runny or blocked nose, itchy, red and watery eyes, a cough, the roof of mouth being itchy). Timepoint: Beginning and end of the study (zero and 60 days). Method of measurement: Using of Sino-Nasal Test 20 (SNOT-20).

Secondary

MeasureTime frame
The level of specific IgE. Timepoint: Beginning and end of the study (zero and 60 days). Method of measurement: Collection of blood samples from patients.;Th1/Th2 cytokines. Timepoint: Beginning and end of the study (zero and 60 days). Method of measurement: Collection of blood samples from patients.;Determination of interferon (IFN)-? concentration. Timepoint: Beginning and end of the study (zero and 60 days). Method of measurement: Collection of blood samples from patients.;Determination of interleukin IL-4 and IL-5 concentrations. Timepoint: Beginning and end of the study (zero and 60 days). Method of measurement: Collection of blood samples from patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mahdi Bakhshaee

Mashhad University of Medical Sciences

bakhshaeem@mums.ac.ir+98 51 3180 1265

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026